<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FIRST
QUARTER ENDED JULY 31, 2000 SYNTHETIC BLOOD INTERNATIONAL, INC.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> APR-30-2001
<PERIOD-START> MAY-01-2000
<PERIOD-END> JUL-31-2000
<CASH> 5,569,914
<SECURITIES> 0
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 5,616,147
<PP&E> 174,967
<DEPRECIATION> 45,973
<TOTAL-ASSETS> 5,991,162
<CURRENT-LIABILITIES> 338,298
<BONDS> 0
0
0
<COMMON> 857,350
<OTHER-SE> 4,795,514
<TOTAL-LIABILITY-AND-EQUITY> 5,991,162
<SALES> 0
<TOTAL-REVENUES> 90,935
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 343,810
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 808
<INCOME-PRETAX> (253,683)
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (253,683)
<EPS-BASIC> (0.003)
<EPS-DILUTED> (0.003)
</TABLE>